Search For "vg somani"
Updated : 2 weeks, 3 days ago IST
New Delhi [India], September 12 (ANI): The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
Updated : 2 months, 1 week ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Updated : 2 months, 2 weeks ago IST
New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to Itolizumab injection for the restricted emergency use on COVID-19 patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to virus.
Updated : 5 months, 1 week ago IST
New Delhi [India], April 20 (ANI): The Indian Council of Medical Research (ICMR) has received 99 applications for participation in "Randomized controlled study to assess the safety and efficacy of convalescent plasma to limit COVID-19 associated complications".